Rakkab starts investing on Research and Development. From 1965 to 1996, the Government's Department of Research, Technology & Application received between 3-5% of Rakkab's annual budget.
Independence of Aurok and Rakkab
The Kingdom of Jeramia granted independence of all its colonies
Privatization of DORTA
February 1996: Rakkab's Parliament adopted legislation to privatize the Department;
April 1996: Privatization of DORTA was effective;
May 1996: DORTA's shares began on the NYSE.
DORTA employed Dr. Bello
During his hospital practice (1998 - 2000), Dr. Bello observed that the incidence of diabetes and obesity was lower in Aurok than in Rakkab
Rural year abroad in Aurok
Dr. Bello spent a year living in rural Aurok, doing fieldwork and investigating Aurokan dietary and cultural practices.
"The Lustuk Enzyme"
Dr. Bello concluded that the discrepancy was correlated with a never-before-identified enzyme found in the gallbladder of the Yak, a key ingredient in Tirhinga Nos Lustuk. He published his findings.
Isolation of the LUSTUK ENZYME
Dr. Bello isolated the Lustuk Enzyme and used it to produce an experimental medication. During the course of 2 years of testing, the drug was proved as highly effective.
DORTA applied for a patent
The medication was named "Gallvectra". According to Rakkabi law, patents are published and are open to complaints, for a period of 18 months. Patent duration: 20 years.
Aurok starts complaining
March: Aurokan Minister wrote to his Rakkabi counterpart, saying that the health benefits of the Yak's enzyme gallbladders were long-known use by the Aurokan people.
April: DORTA's attorneys replied, saying that the isolation of the Lustuk Enzyme and its discovery as a medical treatment of insulin-resistant diseases was the real invent.